Cargando…

SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease

Nesfastin-1 is a recently discovered anorexigenic neuropeptide, which seems to follow the signaling pathway of melanocortin, and is involved in cardiovascular regulation (1). It is expressed in several tissues, including pancreatic islet cells, the central nervous system, In subcutaneous and viscera...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutierrez, Karla Paola, Kornhauser, Carlos, Gómez, Armando, Luevano-Contreras, Claudia, Fafutis-Morris, Mary, Gugliucci, Alejandro, Garay-Sevilla, Ma Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208809/
http://dx.doi.org/10.1210/jendso/bvaa046.673
_version_ 1783530933130887168
author Gutierrez, Karla Paola
Kornhauser, Carlos
Gómez, Armando
Luevano-Contreras, Claudia
Fafutis-Morris, Mary
Gugliucci, Alejandro
Garay-Sevilla, Ma Eugenia
author_facet Gutierrez, Karla Paola
Kornhauser, Carlos
Gómez, Armando
Luevano-Contreras, Claudia
Fafutis-Morris, Mary
Gugliucci, Alejandro
Garay-Sevilla, Ma Eugenia
author_sort Gutierrez, Karla Paola
collection PubMed
description Nesfastin-1 is a recently discovered anorexigenic neuropeptide, which seems to follow the signaling pathway of melanocortin, and is involved in cardiovascular regulation (1). It is expressed in several tissues, including pancreatic islet cells, the central nervous system, In subcutaneous and visceral fat tissue, among others (2). There are few and controversial data that assess the levels of nesfatin-1 and its relationship with the cardiovascular disease. The aim of this study was to evaluate the serum levels of nesfatin-1 in adolescents with different metabolic status and BMI and its association with cardiovascular risk factors (glucose, lipid profile). Material and methods: This cross-sectional study included adolescents between 15 and 19 years old, classified in 3 groups according to BMI and HOMA-IR: adolescents with normal weight without metabolic alterations (n ​​= 30), metabolically healthy obese (MHO) n = 30 and metabolically unhealthy obese adolescents (MUO) n = 42. Anthropometric measurements were performed, a fasting blood sample was taken to quantify glucose, lipid profile and creatinine. Insulin and nesfatin-1 concentrations were measured by ELISA. Statistical tests employed were Kruskal Wallis, Spearman correlation. Results: the group of adolescents MUO had higher levels of total-C (p<0.0002); triglycerides (p<0.00001) compared to the control and MHO; higher levels of nesfatin-1 (p=0.0002) and lower levels of HDL-C (p<0.002) compared to the control group. A positive correlation was between nesfatin-1 and BMI (p<0.001), triglycerides (p<0.027), and HOMA-IR (p<0.025) and negative correlation with HDL-C (p<0.026) Conclusion: Our results show that metabolically unhealthy obese adolescents have higher concentrations of nesfatin-1, showing an association with traditional cardiovascular risk factors, which could lead to the development of cardiovascular disease. Nothing to disclose GK, KC, GOA, LCC, FMM, GA, GSME Sources of research support: Grant University of Guanajuato (DAIP 302/2018) References: (1) Oh-I et al., Nature. 2006; 443:709–712. (2) Stengel A et al., Regulatory Peptides. 2010; 163:18–23
format Online
Article
Text
id pubmed-7208809
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72088092020-05-13 SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease Gutierrez, Karla Paola Kornhauser, Carlos Gómez, Armando Luevano-Contreras, Claudia Fafutis-Morris, Mary Gugliucci, Alejandro Garay-Sevilla, Ma Eugenia J Endocr Soc Cardiovascular Endocrinology Nesfastin-1 is a recently discovered anorexigenic neuropeptide, which seems to follow the signaling pathway of melanocortin, and is involved in cardiovascular regulation (1). It is expressed in several tissues, including pancreatic islet cells, the central nervous system, In subcutaneous and visceral fat tissue, among others (2). There are few and controversial data that assess the levels of nesfatin-1 and its relationship with the cardiovascular disease. The aim of this study was to evaluate the serum levels of nesfatin-1 in adolescents with different metabolic status and BMI and its association with cardiovascular risk factors (glucose, lipid profile). Material and methods: This cross-sectional study included adolescents between 15 and 19 years old, classified in 3 groups according to BMI and HOMA-IR: adolescents with normal weight without metabolic alterations (n ​​= 30), metabolically healthy obese (MHO) n = 30 and metabolically unhealthy obese adolescents (MUO) n = 42. Anthropometric measurements were performed, a fasting blood sample was taken to quantify glucose, lipid profile and creatinine. Insulin and nesfatin-1 concentrations were measured by ELISA. Statistical tests employed were Kruskal Wallis, Spearman correlation. Results: the group of adolescents MUO had higher levels of total-C (p<0.0002); triglycerides (p<0.00001) compared to the control and MHO; higher levels of nesfatin-1 (p=0.0002) and lower levels of HDL-C (p<0.002) compared to the control group. A positive correlation was between nesfatin-1 and BMI (p<0.001), triglycerides (p<0.027), and HOMA-IR (p<0.025) and negative correlation with HDL-C (p<0.026) Conclusion: Our results show that metabolically unhealthy obese adolescents have higher concentrations of nesfatin-1, showing an association with traditional cardiovascular risk factors, which could lead to the development of cardiovascular disease. Nothing to disclose GK, KC, GOA, LCC, FMM, GA, GSME Sources of research support: Grant University of Guanajuato (DAIP 302/2018) References: (1) Oh-I et al., Nature. 2006; 443:709–712. (2) Stengel A et al., Regulatory Peptides. 2010; 163:18–23 Oxford University Press 2020-05-08 /pmc/articles/PMC7208809/ http://dx.doi.org/10.1210/jendso/bvaa046.673 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Cardiovascular Endocrinology
Gutierrez, Karla Paola
Kornhauser, Carlos
Gómez, Armando
Luevano-Contreras, Claudia
Fafutis-Morris, Mary
Gugliucci, Alejandro
Garay-Sevilla, Ma Eugenia
SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease
title SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease
title_full SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease
title_fullStr SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease
title_full_unstemmed SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease
title_short SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease
title_sort sun-575 levels of nesfatin-1 in adolescents, and its association with body mass index and risk of cardiovascular disease
topic Cardiovascular Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208809/
http://dx.doi.org/10.1210/jendso/bvaa046.673
work_keys_str_mv AT gutierrezkarlapaola sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease
AT kornhausercarlos sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease
AT gomezarmando sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease
AT luevanocontrerasclaudia sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease
AT fafutismorrismary sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease
AT gugliuccialejandro sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease
AT garaysevillamaeugenia sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease